Figure 2. Summary of the cardiovascular and renal outcomes of empagliflozin in patients with heart failure with reduced ejection fraction.
Image credits: Sreekartthik Athiyaman
NT: N-terminal
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.